Levetiracetam Tablet, Film Coated
Product Images NDC 50090-2875

10 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 50090-2875). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levetiracetamtabletsstructure (Levetiracetamtabletsstructure)

Levetiracetamtabletsstructure (Levetiracetamtabletsstructure)
Chemical structure diagram of levetiracetam, showing its molecular formula with a pyrrolidone ring, an ethyl group, and an amide functional group.*
FDA Label Image

Levetiracetamtabletsfigure1 (Levetiracetamtabletsfigure1)

Levetiracetamtabletsfigure1 (Levetiracetamtabletsfigure1)
A bar chart depicting the percentage of patients across three groups: Placebo (7.4%, N=95), Levetiracetam 1000 mg/day (37.1%, N=97), and Levetiracetam 3000 mg/day (39.6%, N=101). The vertical axis represents the percentage of patients, ranging from 0% to 45%. Each bar is labeled with its corresponding percentage and includes an asterisk indicating statistical significance.*
FDA Label Image

Levetiracetamtabletsfigure2 (Levetiracetamtabletsfigure2)

Levetiracetamtabletsfigure2 (Levetiracetamtabletsfigure2)
A bar chart comparing the percentage of patients across three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 2000 mg/day. The y-axis shows the percentage of patients from 0% to 45%, with the highest percentage in the Levetiracetam 2000 mg/day group at 35.2%, followed by Levetiracetam 1000 mg/day at 20.8%, and Placebo at 6.3%.*
FDA Label Image

Levetiracetamtabletsfigure3 (Levetiracetamtabletsfigure3)

Levetiracetamtabletsfigure3 (Levetiracetamtabletsfigure3)
A bar graph comparing the percentage of patients between two groups: Placebo (N=104) and Levetiracetam 3000 mg/day (N=180). The y-axis represents the percentage of patients, showing approximately 14.4% for the placebo group and 39.4% for the Levetiracetam group, indicating a higher percentage in the Levetiracetam treatment group.*
FDA Label Image

Levetiracetamtabletsfigure4 (Levetiracetamtabletsfigure4)

Levetiracetamtabletsfigure4 (Levetiracetamtabletsfigure4)
A bar chart comparing the percentage of patients between placebo (N=97) and Levetiracetam (N=101). The placebo group has about 19.6% of patients, while the Levetiracetam group shows approximately 44.6%. The y-axis represents the percentage of patients from 0% to 45%.*
FDA Label Image

Levetiracetamtabletsfigure5 (Levetiracetamtabletsfigure5)

Levetiracetamtabletsfigure5 (Levetiracetamtabletsfigure5)
A bar chart comparing the percentage of patients between two groups: Placebo (N=51) with 19.6% and Levetiracetam (N=58) with 43.1%. The vertical axis represents the percentage of patients from 0% to 45%.*
FDA Label Image

Levetiracetamtabletsfigure6 (Levetiracetamtabletsfigure6)

Levetiracetamtabletsfigure6 (Levetiracetamtabletsfigure6)
Bar chart comparing the percentage of patients between placebo and Levetiracetam groups. The chart shows 45.2% of patients in the placebo group (N=84) and 72.2% in the Levetiracetam group (N=79). The y-axis represents percentage of patients from 0% to 100%, highlighting a higher percentage in the Levetiracetam group.*
FDA Label Image
FDA Label Image

Label Image (Lbl500901333)

Label Image (Lbl500901333)
Levetiracetam 500 mg film-coated tablets label showing product and manufacturer details. The label indicates the dosage form as oral tablets, with each coated tablet containing 500 mg of levetiracetam. The package contains 120 tablets and is labeled by A-S Medication Solutions, Libertyville, IL 60048. Storage instructions specify to keep between 68 and 77 degrees Fahrenheit.*
FDA Label Image

Label Image (Lbl500902875)

Label Image (Lbl500902875)
Levetiracetam 1000 mg film-coated tablets bottle label showing product name, strength, and dosage form. The label includes storage instructions to keep between 68 to 77 degrees Fahrenheit, package size of 30 tablets, and manufacturer A-S Medication Solutions, Libertyville, IL 60048. Additional details include NDC 50090-2875-0 and a QR code for dosage and packaging information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.